The Effects Of Safe Swadding On Newborns' Oxygen Saturation And Comfort Level
Launched by AYSE SONAY TURKMEN, PROF.DR · Mar 26, 2025
Trial Information
Current as of April 29, 2025
Completed
Keywords
ClinConnect Summary
The population of the study consisted of preterm newborns receiving treatment in the Tertiary Neonatal Intensive Care Unit of X University Medical Faculty Hospital. Preterm babies between 30-36 weeks of gestation were included in the sample. The sample size of the study was accepted as type 1 error probability (α) 0.05 (95% confidence level) and type 2 error probability (β) 0.10 (80% power level), taking into account the known score in the G\*Power 3.1.5 program. The sample size was determined as 32 for each group. However, since it was thought that there might be loss during the analysis, ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The baby's gestational age to be between 30 weeks and 36 weeks,
- • The baby's birth weight to be 1250 grams or more,
- • The baby's oxygen requirement to be 40% or less,
- • The baby's to be between 4-28 days old,
- • The swaddling to be done by the same nurse,
- • Parents must agree to participate in the study.
- Exclusion Criteria:
- • • In our study, the babies were not followed up during the first 72 hours because of possible interventions such as giving them surfactant, exposing them to more invasive procedures, and taking heel blood resulting fluctuations in their vital signs.
- • The baby's having any kind of congenital anomalies.
- • There being a situation that prevents swaddling.
- • Criteria for dropping from the study while the study is ongoing
- • When the baby loses his/her life,
- • When the family gives up participating in the study,
- • When the baby is intubated.
About Ayse Sonay Turkmen, Prof.Dr
Prof. Dr. Ayse Sonay Turkmen is a distinguished clinical trial sponsor with extensive expertise in medical research and a commitment to advancing healthcare through innovative clinical studies. With a robust academic background and a proven track record in conducting rigorous trials, Prof. Turkmen is dedicated to ensuring the integrity and efficacy of research methodologies. Her leadership fosters collaboration among multidisciplinary teams, aiming to translate scientific findings into impactful clinical applications. Through her work, she strives to enhance patient outcomes and contribute to the body of knowledge in her field.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Karaman, , Turkey
Karaman, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported